These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 23242060

  • 41. Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer.
    Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, Mancini M.
    Radiol Med; 2008 Sep; 113(6):895-904. PubMed ID: 18414809
    [Abstract] [Full Text] [Related]

  • 42. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
    Winter A, Henke RP, Wawroschek F.
    BMC Urol; 2015 Feb 21; 15(1):10. PubMed ID: 25881245
    [Abstract] [Full Text] [Related]

  • 43. [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.
    Rinnab L, Simon J, Hautmann RE, Cronauer MV, Hohl K, Buck AK, Reske SN, Mottaghy FM.
    World J Urol; 2009 Oct 21; 27(5):619-25. PubMed ID: 19234708
    [Abstract] [Full Text] [Related]

  • 44. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F, Malizia C, Ferrari M, Rigatti P, Fonti C, Martorana G, Fanti S.
    Eur J Nucl Med Mol Imaging; 2016 Aug 21; 43(9):1601-10. PubMed ID: 26960562
    [Abstract] [Full Text] [Related]

  • 45. Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.
    Verburg FA, Pfister D, Heidenreich A, Vogg A, Drude NI, Vöö S, Mottaghy FM, Behrendt FF.
    Eur J Nucl Med Mol Imaging; 2016 Mar 21; 43(3):397-403. PubMed ID: 26563121
    [Abstract] [Full Text] [Related]

  • 46. Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early ¹⁸F-FCH PET/CT?
    Di Biagio D, Chiaravalloti A, Tavolozza M, Abbatiello P, Schillaci O.
    Ann Nucl Med; 2015 Dec 21; 29(10):861-9. PubMed ID: 26261000
    [Abstract] [Full Text] [Related]

  • 47. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?
    Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, Langsteger W.
    Mol Imaging Biol; 2006 Dec 21; 8(1):43-8. PubMed ID: 16315004
    [Abstract] [Full Text] [Related]

  • 48. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
    Reske SN, Blumstein NM, Glatting G.
    Eur J Nucl Med Mol Imaging; 2008 Jan 21; 35(1):9-17. PubMed ID: 17828534
    [Abstract] [Full Text] [Related]

  • 49. Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.
    Hodolič M, Maffione AM, Fettich J, Gubina B, Cimitan M, Rubello D.
    Clin Nucl Med; 2013 Sep 21; 38(9):739-40. PubMed ID: 23816948
    [Abstract] [Full Text] [Related]

  • 50. Comparison Between 64Cu-PSMA-617 PET/CT and 18F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical Recurrence.
    Cantiello F, Crocerossa F, Russo GI, Gangemi V, Ferro M, Vartolomei MD, Lucarelli G, Mirabelli M, Scafuro C, Ucciero G, De Cobelli O, Morgia G, Damiano R, Cascini GL.
    Clin Genitourin Cancer; 2018 Oct 21; 16(5):385-391. PubMed ID: 29937067
    [Abstract] [Full Text] [Related]

  • 51. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
    Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI.
    Clin Nucl Med; 2012 Jul 21; 37(7):637-43. PubMed ID: 22691503
    [Abstract] [Full Text] [Related]

  • 52. [¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.
    Giovacchini G, Incerti E, Mapelli P, Kirienko M, Briganti A, Gandaglia G, Montorsi F, Gianolli L, Picchio M.
    Eur J Nucl Med Mol Imaging; 2015 May 21; 42(6):877-84. PubMed ID: 25697127
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment.
    Detti B, Scoccianti S, Franceschini D, Cipressi S, Cassani S, Villari D, Gacci M, Pupi A, Vaggelli L, Saieva C, Pertici M, Livi L, Ceroti M, Nicita G, Carini M, Biti G.
    J Cancer Res Clin Oncol; 2013 Mar 21; 139(3):521-8. PubMed ID: 23183655
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
    Winter A, Uphoff J, Henke RP, Wawroschek F.
    Aktuelle Urol; 2009 Sep 21; 40(5):294-9. PubMed ID: 19533582
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
    Giovacchini G, Picchio M, Garcia-Parra R, Mapelli P, Briganti A, Montorsi F, Gianolli L, Messa C.
    J Urol; 2013 Jan 21; 189(1):105-10. PubMed ID: 23164385
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.